Additionally, miR-205 is downregulated in pancreatic cancer and its overexpression decreases the expression of both general stemness markers such as OCT-3/4 and NANOG and more specifically pancreatic CSC markers, including CD44 and ALDH1 [90]. Here, CD44 is linked to pancreatic neoplasm.